Jecko Thachil/LinkedIn
Mar 9, 2026, 14:10
Jecko Thachil: The Journey of Protamine – From Heparin Reversal to Potential Gene Therapy Applications
Jecko Thachil, Consultant Haematologist at NHS, shared a post on LinkedIn about his recent article, adding:
“Protamine is a very useful drug in reversing heparin and has been used for several years.
How did its journey start from the discovery of DNA and now may be relevant for gene therapy?”
Title: Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy
Author: Jecko Thachil
Read the Full Article on Seminars in Thrombosis and Hemostasis
Other posts featuring Jecko Thachil on Hemostasis Today.
-
Apr 16, 2026, 14:05Saleh Shamse Basha: When Platelet Counts Mislead, The PLT-F Becomes Critical
-
Apr 16, 2026, 13:44Maha Othman: Celebrating National Medical Laboratory Week in Canada
-
Apr 16, 2026, 13:42Megan Adediran: How Much of What You Know About Hemophilia Is True?
-
Apr 16, 2026, 13:35Priya Singh: How to Write the Discussion of a Research Paper
-
Apr 16, 2026, 13:14Veronica Sanchez: Blood Pressure Categories for Individuals Who Are Pregnant
-
Apr 16, 2026, 13:07Abdul Mannan: Acute Anaphylactic Reaction During Blood Transfusion
-
Apr 16, 2026, 09:41Wolfgang Miesbach: Adeno-Associated Virus Neutralizing Antibodies and Their Clinical Impact on Gene Therapy
-
Apr 16, 2026, 09:33Jeyaraj Pandian: Low-Cost Stroke Rehabilitation Technologies at MENA-VINM 2026
-
Apr 16, 2026, 09:21Aurore Ughetto: The Hemocompatibility Burden of Micro-Axial Flow Pump Support